https://scholars.lib.ntu.edu.tw/handle/123456789/523426
標題: | Suppression of Drug-Resistant Non-Small-Cell Lung Cancer with Inhibitors Targeting Minichromosomal Maintenance Protein | 作者: | Lin C.-Y. Wu H.-Y. Hsu Y.-L. Cheng T.-J.R. Liu J.-H. Huang R.-J. Hsiao T.-H. Wang C.-J. Hung P.-F. Lan A. SZU-HUA PAN Chein R.-J. Wong C.-H. PAN-CHYR YANG |
公開日期: | 2020 | 出版社: | American Chemical Society | 卷: | 63 | 期: | 6 | 起(迄)頁: | 3172-3187 | 來源出版物: | Journal of Medicinal Chemistry | 摘要: | Drug resistance has been a major threat in cancer therapies that necessitates the development of new strategies to overcome this problem. We report here a cell-based high-throughput screen of a library containing two-million molecules for the compounds that inhibit the proliferation of non-small-cell lung cancer (NSCLC). Through the process of phenotypic screening, target deconvolution, and structure-activity relationship (SAR) analysis, a compound of furanonaphthoquinone-based small molecule, AS4583, was identified that exhibited potent activity in tyrosine kinase inhibitor (TKI)-sensitive and TKI-resistant NSCLC cells (IC50 = 77 nM) and in xenograft mice. The mechanistic studies revealed that AS4583 inhibited cell-cycle progression and reduced DNA replication by disrupting the formation of the minichromosomal maintenance protein (MCM) complex. Subsequent SAR study of AS4583 gave compound RJ-LC-07-48 which exhibited greater potency in drug-resistant NSCLC cells (IC50 = 17 nM) and in mice with H1975 xenograft tumor. ? 2020 American Chemical Society. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85082542500&doi=10.1021%2facs.jmedchem.9b01783&partnerID=40&md5=ee8b285ecb6c05167040f5e0e9569d49 https://scholars.lib.ntu.edu.tw/handle/123456789/523426 |
ISSN: | 0022-2623 | DOI: | 10.1021/acs.jmedchem.9b01783 | SDG/關鍵字: | antineoplastic agent; as 4583; caspase 3; furanone derivative; minichromosome maintenance protein; minichromosome maintenance protein 2; n [3 (1h imidazol 1 yl)propyl] 2 methyl 4,9 dioxo 4,9 dihydronaphtho[2,3 b]furan 3 carboxamide; n [3 (1h imidazol 1 yl)propyl] 7 fluoro 2 methyl 4,9 dioxo 4,9 dihydronaphtho[2,3 b]furan 3 carboxamide; naphthalene derivative; nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase 1; protein inhibitor; protein tyrosine kinase inhibitor; quinone derivative; rj lc 07 48; short hairpin RNA; unclassified drug; antineoplastic agent; enzyme inhibitor; furan derivative; minichromosome maintenance protein; naphthoquinone; protein binding; amino terminal sequence; animal experiment; animal model; antineoplastic activity; antiproliferative activity; apoptosis; Article; cancer resistance; cancer size; cell cycle arrest; cell cycle M phase; cell cycle progression; cell cycle S phase; cell survival; cell synchronization; cell viability; chemosensitivity; clinical outcome; controlled study; DNA replication; drug cytotoxicity; drug efficacy; drug potency; HBEC cell line (bronchial epithelium); high throughput screening; human; human cell; IC50; in vivo study; lung non-small cell carcinoma cell line; male; mouse; non small cell lung cancer; nonhuman; overall survival; protein expression; structure activity relation; Sulfolobus solfataricus; tumor growth inhibition rate; tumor xenograft; animal; binding site; cell proliferation; chemical structure; drug effect; drug resistance; drug screening; lung tumor; metabolism; molecular docking; molecular library; non small cell lung cancer; nude mouse; pharmacology; synthesis; tumor cell line; ubiquitination; Animals; Antineoplastic Agents; Binding Sites; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Furans; High-Throughput Screening Assays; Humans; Lung Neoplasms; Mice, Nude; Minichromosome Maintenance Proteins; Molecular Docking Simulation; Molecular Structure; Naphthoquinones; Protein Binding; Small Molecule Libraries; Structure-Activity Relationship; Ubiquitination; Xenograft Model Antitumor Assays |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。